Biocept (NASDAQ:BIOC) reported quarterly losses of $(0.33) per share. This is a 725 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $5.59 million in sales this quarter. This is a 68.02 percent decrease over sales of $17.47 million the same period last year.
P/E Ratio Insights for Becton Dickinson
Looking into the current session, Becton Dickinson Inc. (NYSE:BDX) shares are trading at $258.80, after a 0.82% drop.…
